# Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

> **NCT02465359** · NA · COMPLETED · sponsor: **University of South Florida** · enrollment: 15 (actual)

## Conditions studied

- Chronic Inflammatory Demyelinating Polyneuropathy

## Interventions

- **DRUG:** Immune Globulin Subcutaneous (Human)

## Key facts

- **NCT ID:** NCT02465359
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2018-03
- **Final completion:** 2021-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02465359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02465359, "Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02465359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*